About
Synuca Tx develops disease-modifying treatments for Parkinson's Disease by targeting the SERCA calcium transporter to repair neuronal calcium imbalances caused by pathological α-Synuclein brain species.
Explore Synuca Tx's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.